Triple combination therapycystic fibrosispwCFCFTR modulators
…Triple combination therapy for people with cystic fibrosis (pwCF) restores the activity of…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,141–1,200 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
food supplements1multi-ion therapy1A-CRA1Antithrombotic therapies1CA1CAB/RPV LA1CACB1CWCPC1DT1Delayed treatment intensification1EUS-CG1EVT-capable1FFX1FURS1GTx1Haematoma block1IO1IPFT1IV/IM SACT1Immediate septoplasty1Incretin-based therapies1LA-CAB/RPV1Limb salvage1NACI1NDIs1Oscillometry1PRT1PVEfLR1Parenteral chemotherapy1Primary repair1ShangRing EIMC1TESS1Verbal counselling1Z-POEM1diaphragmatic stimulation1epidural neuroplasty1frenotomy1haematopoietic stem cell transplant1heDMTs1internal fixation1laughter yoga1leDMTs1psychotropic drug prescription1shoulder replacement surgery1telestroke1CES1CESDT1CMH1Capsule sponge testing1Compression therapy1DCB1DMEK1ECPR1EVOKE therapy1FLST1Focal therapy1GLP-1-based therapy1GPD-CBT1ICAS1IERITA1
Articles mentioning treatments
7,227 articles · page 588 of 603immunotherapytype 1 diabetesUKmedicines regulator
…The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in p…
medicationThe BMJattention deficit/hyperactivity disorderADHD
…People who take medication for newly diagnosed attention deficit/hyperactivity disorder (A…
insulin therapypancreatic cancermetastatic melanomaCPI-D
… CPI for metastatic melanoma was complicated by CPI-D requiring insulin therapy. The patient then went on to develop pancreatic cancer. In the …
79.9%
antimigraine therapiesmigraineanti-CGRP mAbsanti-CGRP monoclonal antibodies
…migraine pathophysiology. It led to the development of specific antimigraine therapies (anti-CGRP monoclonal antibodies (anti-CGRP mAbs)), but challen…
medicationstirzepatidefinerenoneGLP-1 receptor agoniststype 2 diabetesSGLT-2 inhibitors
…d recognise that the lack of availability or high costs of some medications may be prohibitive and will impact on how these recommendations…
76.3%
usual careandexanet alfafactor Xa inhibitor-associated ICHfactor Xa inhibitor-associated intracranial haemorrhage (ICH)usual care
…emostatic efficacy (RR=1.16; 95% CI=1.06 to 1.26) compared with usual care, while excellent haemostatic efficacy (RR=1.04; 95% CI=0.85 to …
pharmacological managementtype 2 diabetes
…Empowering choice in the pharmacological management of type 2 diabetes…
antihypertensive therapyhypertrophic cardiomyopathyNoonan syndromehypertensionasthmaoesophagitisHCM
…t pain, palpitations, dizziness, and syncopal episodes. Despite antihypertensive therapy, his blood pressure remained persistently elevated, prompting a…
immunosuppressionPrednisoloneMethotrexatecardiac sarcoidosissarcoidosismanchester royal infirmary
… cardiac complications and subsequent management including both immunosuppression and cardiac implantable electronic devices (CIED).Results The c…
valve replacementCarcinoid heart diseaseright-sided valve diseaseCHDNET centres
…cular (RV) dilatation and failure. The mainstay of treatment is valve replacement when patients are symptomatic with severe valvular disease and/…
specialised treatmentsarrythmiacardiomyopathiesfibrosis
… the process of genetic testing and prevents the development of specialised treatments.This study hypothesises the variants identified to cause disrup…